National Vision (EYE)
(Real Time Quote from BATS)
$11.84 USD
+0.33 (2.87%)
Updated Nov 11, 2024 01:36 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Price, Consensus and EPS Surprise
EYE 11.84 +0.33(2.87%)
Will EYE be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for EYE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EYE
National Vision (EYE) Q3 Earnings Surpass Estimates
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
EYE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Earnings Preview: National Vision (EYE) Q3 Earnings Expected to Decline
Exclusive Partnership With Pair Eyewear Likely to Support EYE Stock
Reasons to Retain EYE Stock in Your Portfolio for Now
Other News for EYE
National Vision price target raised to $33 from $28 at Chardan
National Vision price target raised by $5 at Chardan, here's why
National Vision price target raised to $12 from $11 at Barclays
National Vision price target raised by $1 at Barclays, here's why
Analysts Offer Insights on Consumer Cyclical Companies: National Vision Holdings (EYE) and Mercadolibre (MELI)